These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32405977)

  • 1. ASO Author Reflection: Tending Towards a Personalized Treatment for Advanced Gastric Cancer Patients by Adding the Conversion Surgery.
    Chen GM; Nie RC; Chen YB
    Ann Surg Oncol; 2020 Oct; 27(11):4261-4262. PubMed ID: 32405977
    [No Abstract]   [Full Text] [Related]  

  • 2. ASO Author Reflections: Systematic Mesogastric Excision as a Universal Concept in Gastric Cancer Surgery.
    Kumamoto T; Shinohara H
    Ann Surg Oncol; 2020 Feb; 27(2):532-533. PubMed ID: 31654162
    [No Abstract]   [Full Text] [Related]  

  • 3. ASO Author Reflections: Borrmann Type as a Characteristic Phenotype of Advanced Gastric Cancer.
    Lee HH
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):778-779. PubMed ID: 30421062
    [No Abstract]   [Full Text] [Related]  

  • 4. [Recognition of specialization of minimally invasive treatment for gastric cancer in the era of precision medicine].
    Zhang H; Sang J; Liu F
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Aug; 20(8):847-851. PubMed ID: 28836240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of Gastric Cancer Treatment: From the Golden Age of Surgery to an Era of Precision Medicine.
    Choi YY; Noh SH; Cheong JH
    Yonsei Med J; 2015 Sep; 56(5):1177-85. PubMed ID: 26256958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing safety and feasibility of minimally invasive surgical approaches for advanced gastric cancer.
    Lianos GD; Rausei S; Dionigi G; Boni L
    Future Oncol; 2016 Jan; 12(1):5-8. PubMed ID: 26616648
    [No Abstract]   [Full Text] [Related]  

  • 7. [Problems for the conversion therapy in advanced gastric cancer].
    Wang PL; Xu HM
    Zhonghua Zhong Liu Za Zhi; 2019 Mar; 41(3):163-167. PubMed ID: 30917448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ASO Author Reflections: Tending Towards a Personalized Medicine for Colorectal Carcinomatosis by Adding the RAS Mutation Status in the Workup for CRS and HIPEC.
    Arjona-Sanchez A; Rodriguez-Ortiz L
    Ann Surg Oncol; 2019 Aug; 26(8):2605-2606. PubMed ID: 31004296
    [No Abstract]   [Full Text] [Related]  

  • 9. ASO Author Reflections: Association Between the Lymph Node Ratio and Survival in Patients with Pathological Stage II/III Gastric Cancer.
    Kano K; Yamada T; Oshima T
    Ann Surg Oncol; 2020 Oct; 27(11):4248-4249. PubMed ID: 32462524
    [No Abstract]   [Full Text] [Related]  

  • 10. ASO Author Reflections: Effect of Noncompliance in Lymph Node Dissection on the Long-Term Survival of Gastric Cancer Patients After Radical Gastrectomy.
    Chen QY; Zhong Q; Lin JL; Li P; Zheng CH; Huang CM
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):719-720. PubMed ID: 31482390
    [No Abstract]   [Full Text] [Related]  

  • 11. ASO Author Reflections: Anastomotic Complications are More Prevalent in Laparoscopic Total Gastrectomy than in Open Total Gastrectomy.
    Sakamoto T; Fujiogi M; Matsui H; Fushimi K; Yasunaga H
    Ann Surg Oncol; 2020 Feb; 27(2):527-528. PubMed ID: 31667728
    [No Abstract]   [Full Text] [Related]  

  • 12. [From standard to precision treatment: the development of surgery for gastric cancer].
    Ji JF; Ji X; Bu ZD
    Zhonghua Wai Ke Za Zhi; 2016 Mar; 54(3):164-8. PubMed ID: 26932881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ASO Author Reflections: Challenges in Centralization and Standardization of Gastrectomy in the United States to Improve Gastric Cancer Outcomes.
    Ikoma N; Mansfield P
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):770-771. PubMed ID: 31605331
    [No Abstract]   [Full Text] [Related]  

  • 14. ASO Author Reflections: Simplified Nomogram Predictive of Survival after R0 Resection for Gastric Cancer.
    Zheng ZF; Lu J; Huang CM
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):733-734. PubMed ID: 30306372
    [No Abstract]   [Full Text] [Related]  

  • 15. ASO Author Reflections: Laparoscopic Hyperthermic Intraperitoneal Chemotherapy for Patients with Metastatic Gastric Cancer.
    Newhook TE; Badgwell BD
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):606-607. PubMed ID: 31069555
    [No Abstract]   [Full Text] [Related]  

  • 16. [Individualized treatment strategies for gastric cancer based on D2 dissection].
    Xu H; Wu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Feb; 19(2):144-7. PubMed ID: 26831877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precision medicine in the adjuvant treatment of gastric cancer.
    Gambardella V; Cervantes A
    Lancet Oncol; 2018 May; 19(5):583-584. PubMed ID: 29567072
    [No Abstract]   [Full Text] [Related]  

  • 18. Minimally Invasive Gastric Surgery.
    Herrera-Almario G; Strong VE
    Ann Surg Oncol; 2016 Nov; 23(12):3792-3797. PubMed ID: 27489058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ASO Author Reflections: Future Prospects of Neoadjuvant Chemotherapy for Gastric Cancer.
    Kano M; Matsubara H
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):721-722. PubMed ID: 31797227
    [No Abstract]   [Full Text] [Related]  

  • 20. Lower rate of conversion using robotic-assisted surgery compared to laparoscopy in completion total gastrectomy for remnant gastric cancer.
    Alhossaini RM; Altamran AA; Cho M; Roh CK; Seo WJ; Choi S; Son T; Kim HI; Hyung WJ
    Surg Endosc; 2020 Feb; 34(2):847-852. PubMed ID: 31139994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.